BMP-7 vs EGF
Head-to-head comparison of BMP-7 (Recombinant Human Bone Morphogenetic Protein-7) and EGF (Human Epidermal Growth Factor) — benefits, dosing, side effects, research data, and where to buy.
| Property | BMP-7 | EGF |
|---|---|---|
| Category | Recovery & Healing | Recovery & Healing |
| Full Name | Recombinant Human Bone Morphogenetic Protein-7 | Human Epidermal Growth Factor |
| Molecular Weight | 35000 Da | 6.0 kDa |
| Half-Life | short, localized exposure | minutes |
| Amino Acids | 139 | 53 |
| Typical Dose | procedure-dependent local implant | 0.04–0.1 mg/cm²/day |
| Route | Local/Implant | Topical |
| Purity | ≥98% | ≥98% |
| Studies Count | 700 | 650 |
| Research Status | Clinical | Clinical |
BMP-7 Benefits
- ✓supports bone formation
- ✓may aid nonunion repair
- ✓promotes connective tissue regeneration
- ✓helps scaffold integration
EGF Benefits
- ✓re-epithelialization
- ✓fibroblast activation
- ✓angiogenesis support
- ✓faster ulcer closure
BMP-7 Dosing
local implantation|single procedural exposure|research or device-specific delivery
EGF Dosing
Topical daily|0.04–0.1 mg/cm²|short courses until granulation/closure
BMP-7 Side Effects
- ⚠local swelling
- ⚠inflammation
- ⚠ectopic mineralization
EGF Side Effects
- ⚠local irritation
- ⚠erythema
- ⚠theoretical hyperproliferation
- ⚠pain at site
Research Overview
BMP-7
rhBMP-7 has a long history in preclinical and clinical literature for bone repair, particularly in challenging healing environments. Its cartilage-related research is less mature than BMP-2 but still relevant to musculoskeletal regeneration.
EGF
Human and animal studies show EGF can accelerate epithelial migration and wound closure, especially in burns, ulcers, and mucosal injury. Its best evidence is for topical or local delivery because systemic exposure is brief and the effect is highly localized.
Ready to buy?
Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.